胃と腸59巻6号

2024年06月発行

今月の主題 内視鏡治療後サーベイランスの現状—異時性多発病変を中心に

主題

食道腫瘍の内視鏡治療後サーベイランス：Barrett食道腺癌

著者： 前田有紀¹ 川田登¹ 吉田将雄¹ 山本陽一¹ 小野裕之¹ 下田忠和²

所属機関： ¹静岡県立静岡がんセンター内視鏡科 ²静岡県立静岡がんセンター病理診断科

ページ範囲：P.820 - P.827

文献概要

要旨●本邦でも欧米と同様にBarrett食道腺癌の頻度は増加傾向であり，今後もBarrett食道腺癌に対する内視鏡治療は増加することが予想される．本邦と欧米では，Barrett食道腺癌内視鏡治療後の方針は大きく異なる．欧米では残存Barrett粘膜に対する内視鏡的焼灼術が施行されるが，本邦のガイドラインではBarrett食道そのものに対して発癌予防目的に内視鏡治療を行うことは推奨されていない．また，Barrett食道腺癌の内視鏡治療後サーベイランスについては，必要性，方法，検査間隔など，定まっていない部分も多い．本稿ではBarrett食道腺癌の内視鏡治療後のサーベイランスについて，本邦と欧米それぞれの最新のガイドラインも含めて解説した．

参考文献

1）Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol　25：982-993, 1994

2）Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol　44：518-534, 2009

3）Nishi T, Makuuchi H, Ozawa S, et al. The present status and future of Barrett's esophageal adenocarcinoma in Japan. Digestion　99：185-190, 2019

4）日本食道学会（編）．臨床・病理 食道癌取扱い規約，第12版．金原出版，2022

5）日本食道学会（編）．食道癌診療ガイドライン　2022年版．金原出版，2022

6）石原立，有馬美和子，飯塚敏郎，他 ; 日本消化器内視鏡学会食道癌に対するESD/EMRガイドライン委員会．食道癌に対するESD/EMRガイドライン．Gastroenterol Endosc　62：221-271, 2020

7）日本消化器病学会（編）．胃食道逆流症（GERD）診療ガイドライン2021，改訂第3版．南江堂，2021

8）Asge Standards of Practice Committee. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc　90：335-359, 2019

9）Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus：European Society of Gastrointestinal Endoscopy（ESGE）position statement. Endoscopy　49：191-198, 2017

10）Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut　63：7-42, 2014

11）Whiteman DC, Appleyard M, Bahin FF, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol　30：804-820, 2015

12）Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus：The Prague C & M criteria. Gastroenterology　131：1392-1399, 2006

13）Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology　146：652-660, 2014

14）Amano Y, Ishimura N, Ishihara S. Is malignant potential of Barrett's esophagus predictable by endoscopy findings? Life（Basel）　10：244, 2020

15）Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett's esophagus：updated prospective multivariate analysis. Am J Gastroenterol　99：1657-1666, 2004

16）Hamade N, Vennelaganti S, Parasa S, et al. Lower annual rate of progression of short-segment vs long-segment Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol　17：864-868, 2019

17）Pohl H, Pech O, Arash H, et al. Length of Barrett's oesophagus and cancer risk：implications from a large sample of patients with early oesophageal adenocarcinoma. Gut　65：196-201, 2016

18）Hamade N, Vennelaganti S, Parasa S, et al. Lower annual rate of progression of short-segment vs long-segment Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol　17：864-868, 2019

19）Chandrasekar VT, Hamada N, Desai M, et al. Significantly lower annual rates of neoplastic progression in short-compared to long-segment non-dysplastic Barrett's esophagus：a systematic review and meta-analysis. Endoscopy　51：665-672, 2019

20）Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus：an updated ACG guideline. Am J Gastroenterol　117：559-587, 2022

21）Matsuhashi N, Sakai E, Ohata K, et al. Surveillance of patients with long-segment Barrett's esophagus：a multicenter prospective cohort study in Japan. J Gastroenterol Hepatol　32：409-414, 2017

22）Fukuda S, Watanabe K, Yoshida T, et al. Low risk of esophageal adenocarcinoma among patients with ultrashort-segment Barrett's esophagus in Japan. Dig Endosc　34：757-765, 2022

23）河野辰幸，神津照雄，大原秀一，他．日本人のBarrett粘膜の頻度．Gastroenterol Endosc　47：951-961, 2005

24）Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut　57：1200-1206, 2008

25）May A, Gossner L, Pech O, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus：acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol　14：1085-1091, 2002

26）Peters FP, Kara MA, Rosmolen WD, et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc　61：506-514, 2005

27）Conio M, Repici A, Cestari R, et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus：an Italian experience. World J Gastroenterol　11：6650-6655, 2005

28）Pech O, May A, Rabenstein T, et al. Endoscopic resection of early oesophageal cancer. Gut　56：1625-1634, 2007

29）Pech O, Gossner L, May A, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc　62：24-30, 2005

30）Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology　146：652-660, 2014

31）Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus：European Society of Gastrointestinal Endoscopy（ESGE）position statement. Endoscopy　49：191-198, 2017

32）Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline：diagnosis and management of Barrett's esophagus. Am J Gastroenterol　111：30-50, 2016

33）Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection：European Society of Gastrointestinal Endoscopy（ESGE）guideline. Endoscopy　47：829-854, 2015

34）Sharma P, Shaheen NJ, Katzka D, et al. AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and/or early cancer：expert review. Gastroenterology　158：760-769, 2020

35）Cassani L, Sumner E, Slaughter JC, et al. Directional distribution of neoplasia in Barrett's esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc　77：877-882, 2013

36）Yamasaki A, Shimizu T, Kawachi H, et al. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus. J Gastroenterol Hepatol　35：211-217, 2020

37）藤崎順子，大前雅実，清水智樹，他．表在型Barrett食道癌の内視鏡診断—拾い上げ診断．胃と腸　51：1299-1310, 2016

38）小山恒男，高橋亜紀子，依光展和，他．表在型Barrett食道癌の側方進展範囲診断．胃と腸　51：1322-1332, 2016

39）Yamagata T, Hirasawa D, Fujita N, et al. Efficacy of acetic acid-spraying method in diagnosing extension of Barrett's cancer under the squamous epithelium. Dig Endosc　24：309-314, 2012

40）Cassani L, Sumner E, Slaughter JC, et al. Directional distribution of neoplasia in Barrett's esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc　77：877-882, 2013

41）Yamasaki A, Shimizu T, Kawachi H, et al. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus. J Gastroenterol Hepatol　35：211-217, 2020

42）Vieth M, Ell C, Gossner L, et al. Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy　36：776-781, 2004

43）Abrams JA, Kapel RC, Lindberg GM, et al. Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol　7：736-742, 2009

44）Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus：a prospective, international, randomised controlled trial. Gut　62：15-21, 2013

45）Curvers WL, Bohmer CJ, Mallant-Hent RC, et al. Mucosal morphology in Barrett's esophagus：interobserver agreement and role of narrow band imaging. Endoscopy　40：799-805, 2008

46）Goda K, Fujisaki J, Ishihara R, et al. Newly developed magnifying endoscopic classification of the Japan Esophageal Society to identify superficial Barrett's esophagus-related neoplasms. Esophagus　15：153-159, 2018

47）Guelrud M, Herrera I. Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy. Gastrointest Endosc　47：512-515, 1998

48）八木一芳，有賀諭生，中村厚夫，他．切開・剝離法（ESD）に必要な胃癌術前診断—新しい診断法：拡大内視鏡．胃と腸　40：791-799, 2005

49）Longcroft-Wheaton G, Duku M, Mead R, et al. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol　8：843-847, 2010

50）Tholoor S, Bhattacharyya R, Tsagkournis O, et al. Acetic acid chromoendoscopy in Barrett's esophagus surveillance is superior to the standardized random biopsy protocol：results from a large cohort study（with video）. Gastrointest Endosc　80：417-424, 2014

51）Oyama T. Diagnostic strategies of superficial Barrett's esophageal cancer for endoscopic submucosal dissection. Dig Endosc　25：7-12, 2013

52）前田有紀，小野裕之，川田登，他．症例から学ぶ，LSBE由来Barrett食道腺癌のESD（Case 5）—ESD後，多発病変の発生を認めた症例．消内視鏡　33：1758-1763, 2021